Hamburger

Call: 1-202-476-5000

   
 
Pressroom
News Releases
Archives
Children's In The News
Video Gallery
Watch Us Grow
Press Kit
Media Sign Up
Contact Us
 
 
Email this page Email This Page
Print this page Print This Page
 

  Join Us On:
  Follow Children's on Facebook  Facebook
  Follow Children's on Twitter  Twitter
  Watch Children's on YouTube  YouTube
 
 
 
     
  Catherine M. Bollard, MBChB, MD, Immunology Expert, Joins Children’s National
October 9, 2013

Washington, DC— Children’s National Health System announced the appointment of Catherine M. Bollard, MBChB, MD, FRACP, FRCPA, as a senior scientist in the Center for Cancer and Immunology Research at the Children’s Research Institute, a member of the Division of the Blood and Marrow Transplantation, and the Principal Investigator and Co-Director of the Immunology Initiative of the Sheikh Zayed Institute for Pediatric Surgical Innovation. In this role, she will lead clinical and research efforts to fight cancer and other inflammatory diseases by strengthening a child’s immune system.

A distinguished hematologist and immunotherapist, Dr. Bollard’s research interests focus on three different areas including developing cell and gene therapies for patients with cancer and underlying immune deficiencies. She is also interested in stem cell and cord blood transplantation, and improving outcomes by decreasing infectious complications and preventing relapse. She also has a specific interest in cell therapies for EBV-associated lymphomas and as head of the NHL committee of the Children’s Oncology Group is moving cell therapies to the cooperative group setting.

“As a leader in the area of immunology/immunotherapy, Dr. Bollard’s work will be an asset to strengthening programs within Children’s Research Institute, the Sheikh Zayed Institute for Pediatric Surgical Innovation, and the Blood and Marrow Transplantation Division,” said Mark Batshaw, MD, Physician-in-Chief and Chief Academic Officer of Children’s National. “Her work will expand our ability to learn about and care for cancer patients.”

Dr. Bollard joins Children’s National from the Baylor College of Medicine where she was a Professor in the Departments of Pediatrics, Medicine and Immunology, at the Center for Cell and Gene Therapy, Texas Children’s Hospital, The Methodist Hospital, and Baylor College of Medicine. She received her medical degree from Otago University Medical School in New Zealand.


Contact:
Emily Hartman or Paula Darte at 202-476-4500.

About Children’s National Health System

Children’s National Health System, based in Washington, DC, has been serving the nation’s children since 1870. Children’s National’s hospital is Magnet® designated, and is consistently ranked among the top pediatric hospitals by U.S.News & World Report and the Leapfrog Group. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is one of the nation’s top NIH-funded pediatric institutions. With a community-based pediatric network, eight regional outpatient centers, an ambulatory surgery center, two emergency rooms, an acute care hospital, and collaborations throughout the region, Children’s National is recognized for its expertise and innovation in pediatric care and as an advocate for all children. For more information, visit ChildrensNational.org, or follow us on Facebook and Twitter.